EXPERT OPINION ON THERAPEUTIC TARGETS Q1区

期刊简介

The journal evaluates molecules, signalling pathways, receptors and other therapeutic targets and their potential as candidates for drug development. Articles in this journal focus on the molecular level and early preclinical studies. Articles should not include clinical information including specific drugs and clinical trials.The Editors welcome:Reviews covering novel disease targets at the molecular level and information on early preclinical studies and their implications for future drug development.Articles should not include clinical information including specific drugs and clinical trials.Original research papers reporting results of target selection and validation studies and basic mechanism of action studies for investigative and marketed drugs.The audience consists of scientists, managers and decision makers in the pharmaceutical industry, academic researchers working in the field of molecular medicine and others closely involved in R&D.

该杂志评估分子、信号通路、受体和其他治疗靶点及其作为药物开发候选物的潜力。该杂志的文章主要集中在分子水平和早期临床前研究。文章不应包含临床信息，包括特定药物和临床试验。编辑欢迎：涵盖分子水平的新疾病靶点的综述，早期临床前研究的信息及其对未来药物开发的影响。文章不应包含临床信息，包括特定药物和临床试验。报告靶点选择和验证研究结果的原创研究论文，以及研究和上市药物的基本作用机制研究。受众包括制药行业的科学家、管理人员和决策者，分子医学领域的学术研究人员和其他密切参与研发的人员。

《EXPERT OPINION ON THERAPEUTIC TARGETS》期刊已被查看： 次

期刊官网投稿信息

分区信息

• 上一篇： IET Science Measurement & Technology
• 下一篇：Expert Review of Proteomics